Search research articles
Contact Us
Filters
Showing results (101-110 of 217) with videos related to
Page
of 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2003
Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors
Amy B Heimberger, Laura E Crotty, Gary E Archer, et al.
Neuro-Oncology
|
February 11, 2005
Mechanisms of action of rapamycin in gliomas
Amy B Heimberger, Enze Wang, Eric C McGary, et al.
Journal of the National Cancer Institute
|
May 4, 2006
Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus
Hideaki Ito, Hiroshi Aoki, Florian Kühnel, et al.
NPJ Breast Cancer
|
March 29, 2020
Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice
Rashmi K Murthy, Juhee Song, Akshara S Raghavendra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2006
Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience
Valentina Guarneri, Daniel J Lenihan, Vicente Valero, et al.
Journal of Neuro-Oncology
|
March 10, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma
Morris D Groves, Kenneth R Hess, Vinay K Puduvalli, et al.
The Oncologist
|
June 10, 2015
The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab
Naifa L Busaidy, Patricia LoRusso, Kristie Lawhorn, et al.
The Lancet. Oncology
|
May 10, 2015
Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
Alexandria T Phan, Daniel M Halperin, Jennifer A Chan, et al.
Journal of Neuro-Oncology
|
March 1, 2005
PAX6 suppresses growth of human glioblastoma cells
Yi-Hong Zhou, Xiaosong Wu, Fang Tan, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 23, 2017
Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma
Priyanka C Iyer, Ramona Dadu, Renata Ferrarotto, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 217) with videos related to
Sort By:
Page
of 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2003
Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors
Amy B Heimberger, Laura E Crotty, Gary E Archer, et al.
Neuro-Oncology
|
February 11, 2005
Mechanisms of action of rapamycin in gliomas
Amy B Heimberger, Enze Wang, Eric C McGary, et al.
Journal of the National Cancer Institute
|
May 4, 2006
Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus
Hideaki Ito, Hiroshi Aoki, Florian Kühnel, et al.
NPJ Breast Cancer
|
March 29, 2020
Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice
Rashmi K Murthy, Juhee Song, Akshara S Raghavendra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2006
Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience
Valentina Guarneri, Daniel J Lenihan, Vicente Valero, et al.
Journal of Neuro-Oncology
|
March 10, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma
Morris D Groves, Kenneth R Hess, Vinay K Puduvalli, et al.
The Oncologist
|
June 10, 2015
The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab
Naifa L Busaidy, Patricia LoRusso, Kristie Lawhorn, et al.
The Lancet. Oncology
|
May 10, 2015
Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
Alexandria T Phan, Daniel M Halperin, Jennifer A Chan, et al.
Journal of Neuro-Oncology
|
March 1, 2005
PAX6 suppresses growth of human glioblastoma cells
Yi-Hong Zhou, Xiaosong Wu, Fang Tan, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 23, 2017
Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma
Priyanka C Iyer, Ramona Dadu, Renata Ferrarotto, et al.
Page
of 22